Clinical parameters | Case | Control | p value |
---|---|---|---|
(n = 124) | (n = 124) | ||
BMI ≥ 23 kg/m 2 (n,%) | 55(44.4) | 26(20.9) | 0.001* |
Elevated blood pressure/ hypertension (n, %) | 24(19.3) | 18(14.5) | 0.32 |
Metabolic syndrome (n, %) | 3(4.3) | 3(3.0) | 0.66 |
Clinically-diagnosed lipodystrophy | 14(11.3) | 10(8.1) | 0.32 |
Laboratory measurement (n, %) | |||
o CD4+ cell count ≤ 200 cells/mm3 | 15(12.1) | 10(8.1) | 0.30 |
o HIV-1 RNA level ≥ 400 copies/ml | 11(8.8) | 16(9.6) | 0.21 |
o Impaired fasting plasma glucose ≥ 100 mg/dL | 15(14.1) | 10(9.6) | 0.21 |
o Total cholesterol ≥ 200 mg/dL | 56(50.4) | 48(42.8) | 0.49 |
o Triglycerides ≥ 150 mg/dL | 40(36.0) | 31(27.7) | 0.29 |
o HDL cholesterol ≤ 40 mg/dL (male) or ≤ 50 mg/dL (female) | 36(34.3) | 22(21.6) | 0.09 |
o LDL cholesterol ≥ 130 mg/dL | 36(34.3) | 25(24.5) | 0.32 |